Advertisement
U.S. Markets close in 31 mins

Vaxxinity, Inc. (VAXX)

OTC Markets EXMKT - OTC Markets EXMKT Delayed Price. Currency in USD
Visitors trend2W10W9M
0.06000.0000 (0.00%)
As of 10:18AM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous Close0.0600
Open0.0600
Bid0.3600 x 0
Ask0.3950 x 0
Day's Range0.0600 - 0.0600
52 Week Range0.0001 - 1.3300
Volume212
Avg. Volume13,675
Market Cap7.607M
Beta (5Y Monthly)2.93
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Exec Edge

    Vaxxinity’s Heart Health Innovation to Reduce LDL Cholesterol Levels

    By Daniella Parra Vaxxinity, Inc. (Nasdaq: VAXX) said it demonstrated that VXX-401 lowers LDL cholesterol, supporting its potential for treating hypercholesterolemia. The VXX-401, a synthetic peptide vaccine, aims to provide a safe and effective solution against heart disease by targeting PCSK9, the company said in a statement. The studies were published in the Journal of […]

  • Exec Edge

    Vaxxinity, UF Join Forces Against Neurodegenerative Diseases

    By Daniella Parra Vaxxinity, Inc. (Nasdaq: VAXX) said it’s with the University of Florida’s Center for Translational Research in Neurodegenerative Disease (CTRND) to develop vaccines for diseases like Alzheimer’s and Parkinson’s. The collaboration aims to understand and neutralize toxic brain proteins, Vaxxinity said. UF researchers will conduct preclinical studies to evaluate candidates and potentially offer […]